ResearcherKumamoto UniversityActive in the last 2 years
Kosuke Mima
Matched on ORCID iD 0000-0002-4385-4984; OpenAlex author ID A5035573322. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2021: 1 paper · 2022: 2 papers · 2023: 4 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 10
- High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Cancer Resection. Co-author DOI 10.1002/jhbp.70032↗
- Molecular Alterations Influencing the Prognostic Outcome in Small Pancreatic Cancer (≤2 cm). Co-author DOI 10.1097/mpa.0000000000002430↗
- Impairment of perioperative activities of daily living is associated with poor prognosis following pancreatectomy for pancreatic cancer. First author DOI 10.1007/s00423-024-03478-7↗
- Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis… Co-author DOI 10.1038/s41416-022-02106-9↗
- The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. Co-author DOI 10.1097/mpa.0000000000002210↗
- Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer. Co-author DOI 10.1172/jci.insight.163022↗
- Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune suppression by downregulating PD-L1 exp… Co-author PMID 37293171↗
- Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2022.101533↗
- High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with Pancreatic Cancer: A Retrospective Study. Co-author DOI 10.1245/s10434-022-11500-9↗
- Frailty is associated with poor prognosis after resection for pancreatic cancer. Co-author DOI 10.1007/s10147-021-01983-z↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiromitsu Hayashi · 10 shared papers, 2021–2026 · strength 1.73
- Paper High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Can… DOI 10.1002/jhbp.70032↗
- Paper Molecular Alterations Influencing the Prognostic Outcome in Small Pancreatic Cancer (≤2 cm). DOI 10.1097/mpa.0000000000002430↗
- Paper Impairment of perioperative activities of daily living is associated with poor prognosis following pancreatectomy for p… DOI 10.1007/s00423-024-03478-7↗
- Shigeki Nakagawa · 8 shared papers, 2021–2025 · strength 1.33
- Paper Molecular Alterations Influencing the Prognostic Outcome in Small Pancreatic Cancer (≤2 cm). DOI 10.1097/mpa.0000000000002430↗
- Paper Impairment of perioperative activities of daily living is associated with poor prognosis following pancreatectomy for p… DOI 10.1007/s00423-024-03478-7↗
- Paper The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. DOI 10.1097/mpa.0000000000002210↗
- Zhao Liu · 6 shared papers, 2022–2026 · strength 1.04
- Paper High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Can… DOI 10.1002/jhbp.70032↗
- Paper The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. DOI 10.1097/mpa.0000000000002210↗
- Paper Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transiti… DOI 10.1038/s41416-022-02106-9↗
- Katsunori Imai · 6 shared papers, 2021–2023 · strength 0.84
- Paper The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. DOI 10.1097/mpa.0000000000002210↗
- Paper Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transiti… DOI 10.1038/s41416-022-02106-9↗
- Paper High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with … DOI 10.1245/s10434-022-11500-9↗
- Takayoshi Kaida · 5 shared papers, 2021–2024 · strength 0.76
- Paper Impairment of perioperative activities of daily living is associated with poor prognosis following pancreatectomy for p… DOI 10.1007/s00423-024-03478-7↗
- Paper The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. DOI 10.1097/mpa.0000000000002210↗
- Paper High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with … DOI 10.1245/s10434-022-11500-9↗
- Norio Uemura · 5 shared papers, 2021–2023 · strength 0.69
- Paper Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transiti… DOI 10.1038/s41416-022-02106-9↗
- Paper Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune… PMID 37293171↗
- Paper Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironmen… DOI 10.1172/jci.insight.163022↗
- Hideo Baba · 4 shared papers, 2022–2023 · strength 0.59
- Paper The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. DOI 10.1097/mpa.0000000000002210↗
- Paper Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transiti… DOI 10.1038/s41416-022-02106-9↗
- Paper Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironmen… DOI 10.1172/jci.insight.163022↗
- Kazuki Matsumura · 4 shared papers, 2021–2023 · strength 0.56
- Paper Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transiti… DOI 10.1038/s41416-022-02106-9↗
- Paper Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune… PMID 37293171↗
- Paper Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation… DOI 10.1016/j.tranon.2022.101533↗
- Takashi Matsumoto · 3 shared papers, 2021–2026 · strength 0.53
- Paper High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Can… DOI 10.1002/jhbp.70032↗
- Paper High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with … DOI 10.1245/s10434-022-11500-9↗
- Paper Frailty is associated with poor prognosis after resection for pancreatic cancer. DOI 10.1007/s10147-021-01983-z↗
- Yuki Kitano · 2 shared papers, 2025–2026 · strength 0.52
- Toru Takematsu · 2 shared papers, 2025–2026 · strength 0.52
- Hirohisa Okabe · 2 shared papers, 2024–2026 · strength 0.49
- Paper High γ-H2AX Predicts Clinical Benefit From Platinum-Based Chemotherapy (mFOLFIRINOX) at Recurrence After Pancreatic Can… DOI 10.1002/jhbp.70032↗
- Paper Impairment of perioperative activities of daily living is associated with poor prognosis following pancreatectomy for p… DOI 10.1007/s00423-024-03478-7↗
- Rumi Itoyama · 3 shared papers, 2021–2024 · strength 0.45
- Paper Impairment of perioperative activities of daily living is associated with poor prognosis following pancreatectomy for p… DOI 10.1007/s00423-024-03478-7↗
- Paper Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironmen… DOI 10.1172/jci.insight.163022↗
- Paper Frailty is associated with poor prognosis after resection for pancreatic cancer. DOI 10.1007/s10147-021-01983-z↗
- Hiroki Sato · 3 shared papers, 2022–2023 · strength 0.45
- Paper Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transiti… DOI 10.1038/s41416-022-02106-9↗
- Paper Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune… PMID 37293171↗
- Paper Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation… DOI 10.1016/j.tranon.2022.101533↗
- Fumimasa Kitamura · 3 shared papers, 2021–2023 · strength 0.37
- Paper Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironmen… DOI 10.1172/jci.insight.163022↗
- Paper Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation… DOI 10.1016/j.tranon.2022.101533↗
- Paper Frailty is associated with poor prognosis after resection for pancreatic cancer. DOI 10.1007/s10147-021-01983-z↗
- Yosuke Nakao · 2 shared papers, 2021–2025 · strength 0.36
- Tatsunori Miyata · 2 shared papers, 2023 · strength 0.32
- Paper Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transiti… DOI 10.1038/s41416-022-02106-9↗
- Paper Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune… PMID 37293171↗
- Chuan Lan · 2 shared papers, 2022–2023 · strength 0.31
- Paper The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. DOI 10.1097/mpa.0000000000002210↗
- Paper High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with … DOI 10.1245/s10434-022-11500-9↗
- Hideo Baba · 2 shared papers, 2022–2023 · strength 0.30
- Paper Statins exert anti-growth effects by suppressing YAP/TAZ expressions via JNK signal activation and eliminate the immune… PMID 37293171↗
- Paper High Expression of Bloom Syndrome Helicase is a Key Factor for Poor Prognosis and Advanced Malignancy in Patients with … DOI 10.1245/s10434-022-11500-9↗
- Shinsei Yumoto · 1 shared paper, 2026 · strength 0.28
- Masaaki Iwatsuki · 1 shared paper, 2026 · strength 0.28
- Hideo Andreas Baba · 1 shared paper, 2025 · strength 0.25
- Takanobu Yamao · 1 shared paper, 2025 · strength 0.25
- Takashi Ofuchi · 1 shared paper, 2024 · strength 0.21
- Yuki Adachi · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.